Correlation Between Caisse Regionale and Maat Pharma
Can any of the company-specific risk be diversified away by investing in both Caisse Regionale and Maat Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caisse Regionale and Maat Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caisse Regionale de and Maat Pharma SA, you can compare the effects of market volatilities on Caisse Regionale and Maat Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caisse Regionale with a short position of Maat Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caisse Regionale and Maat Pharma.
Diversification Opportunities for Caisse Regionale and Maat Pharma
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Caisse and Maat is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Caisse Regionale de and Maat Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maat Pharma SA and Caisse Regionale is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caisse Regionale de are associated (or correlated) with Maat Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maat Pharma SA has no effect on the direction of Caisse Regionale i.e., Caisse Regionale and Maat Pharma go up and down completely randomly.
Pair Corralation between Caisse Regionale and Maat Pharma
Assuming the 90 days trading horizon Caisse Regionale is expected to generate 1.7 times less return on investment than Maat Pharma. But when comparing it to its historical volatility, Caisse Regionale de is 2.06 times less risky than Maat Pharma. It trades about 0.1 of its potential returns per unit of risk. Maat Pharma SA is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 730.00 in Maat Pharma SA on September 3, 2024 and sell it today you would earn a total of 64.00 from holding Maat Pharma SA or generate 8.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Caisse Regionale de vs. Maat Pharma SA
Performance |
Timeline |
Caisse Regionale |
Maat Pharma SA |
Caisse Regionale and Maat Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caisse Regionale and Maat Pharma
The main advantage of trading using opposite Caisse Regionale and Maat Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caisse Regionale position performs unexpectedly, Maat Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maat Pharma will offset losses from the drop in Maat Pharma's long position.The idea behind Caisse Regionale de and Maat Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Maat Pharma vs. OSE Pharma SA | Maat Pharma vs. Abivax SA | Maat Pharma vs. Acticor Biotech SAS | Maat Pharma vs. Waga Energy SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |